The formation of antibodies against immunoglobulins is typical of rheumatoid arthritis (RA). These antibodies are known as the rheumatoid factors. With respect to responses in vivo against various antigens and observed levels of serum immunoglobulins there is controversy about antibody formation in RA. However, the majority of studies have demonstrated elevated levels of IgG, IgM, and IgA.' Although in-vitro methods for studying antibody response at the cellular level have been used in laboratory animals for several years, only recently has it been possible to apply the same methodology to human cells. A major advance in this respect has been the development of plaque assays, in which the number of cells secreting various classes of immunoglobulins after stimulation with a mitogen is determined.23 Using this plaque technique and an enzyme-linked immunosorbent assay (ELISA) we studied the synthesis of IgG, IgM, and IgA in patients suffering from RA.
Materials and methods
Subjects. Fifteen patients with active, definite rheumatoid arthritis according to the ARA criteria were selected for study ( (Fig. 4) There is an apparent contradiction between these results and the high levels of antibodies detected in rheumatoid sera. Decreased antibody production should result in low levels of immunoglobulins in serum. A similar discrepancy was reported in patients with SLE whose peripheral blood B cells showed impaired immunoglobulin synthesis after' PWM stimulation.'2 '3 However, it should be kept in mind that in-vitro studies are performed on blood lymphocytes. It may well be that lymphocytes actively,synthesising immunoglobulins are present in other sites such as synovial tissue. Furthermore, all the mechanisms regulating antibody response in vivo may not be present in cell cultures.
As already discussed, the explanation for the impairment of antibody synthesis in RA is not clear. We would like to think that in RA, possibly after polyclonal stimulation,'4 a too vigorous antibody response takes place. The immune system thus has to use powerful mechanisms of regulation to avoid immunological exhaustion. What we see in vitro would be consistent with this state of affairs. 
